The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Sight Sciences (SGHT) announced the publication of a landmark 36-month analysis evaluating the long-term effectiveness of the OMNI Surgical ...

Barclays PLC increased its holdings in shares of Sight Sciences, Inc. (NASDAQ:SGHT – Free Report) by 317.4% during the 3rd ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...

Dihydropyridine CCBs may raise the risk of glaucoma, suggests a study published in the Ophthalmology Glaucoma.A study was ...

Latanoprost SR is under clinical development by Peregrine Ophthalmic and currently in Phase I for Unspecified Ophthalmological Disorders.

Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.

Shanghai BDgene Therapeutics is a biotechnology company engaged in research and development of gene therapies for the treatment of genetic diseases. The company is headquartered in Shanghai City, ...

Electrical stimulation therapy is being explored as a potential treatment to enhance neuroplasticity and improve visual ...

A new study “Prevalence of Glaucoma Among US Adults in 2022” published in JAMA Ophthalmology, found that approximately 4.22 million people in the U.S. have glaucoma, and 1.49 million people have ...

A 2019 analysis of nearly 137,000 participants in three population studies found no connection between statin use and the risk for primary open-angle glaucoma. A 2012 study of more than 500,000 ...